NDC 54868-3319

NDC 54868-3319

NDC 54868-3319 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 54868-3319
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 54868-3319-5 [54868331905]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074223
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1994-11-18
Inactivation Date2019-09-24

NDC 54868-3319-7 [54868331907]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074223
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1994-11-18
Inactivation Date2019-09-24

NDC 54868-3319-6 [54868331906]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074223
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1994-11-18
Inactivation Date2019-09-24

NDC 54868-3319-1 [54868331901]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074223
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1994-11-18
Inactivation Date2019-09-24

NDC 54868-3319-4 [54868331904]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074223
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1994-11-18
Inactivation Date2019-09-24

NDC 54868-3319-2 [54868331902]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074223
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1994-11-18
Inactivation Date2019-09-24

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.